Drug Interactions between Crixivan and milk thistle
This report displays the potential drug interactions for the following 2 drugs:
- Crixivan (indinavir)
- milk thistle
Interactions between your drugs
indinavir milk thistle
Applies to: Crixivan (indinavir) and milk thistle
Milk thistle does not appear to substantially alter the pharmacokinetics of indinavir. Compared to indinavir alone at baseline, milk thistle 175 mg (confirmed to contain silymarin 153 mg) given 3 times a day for three weeks to ten healthy volunteers led to an insignificant 9% reduction in the 8-hour area under the plasma concentration-time curve (AUC) of indinavir, given as 800 mg orally every 8 hours for four doses. However, the mean trough level of indinavir was significantly decreased by 25%, and one subject had a 60% decrease. Following an 11-day washout period indinavir dosing was repeated, which resulted in mean Cmax, AUC, and trough levels that were approximately 22% to 28% lower than at baseline. Whether these changes are due to a time-dependent effect or a delayed effect of milk thistle or some metabolite is unknown. However, these changes are fairly small and not thought to be clinically important. The 60% decrease in indinavir trough level in the one subject might be of some significance; however, its occurrence is probably highly variable. In general, patients should consult a healthcare provider before taking any herbal or alternative medicine.
References (1)
- Piscitelli SC, Formentini E, Burstein AH, Alfaro R, Jagannatha S, Falloon J (2002) "Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers." Pharmacotherapy, 22, p. 551-6
Drug and food interactions
indinavir food
Applies to: Crixivan (indinavir)
ADJUST DOSING INTERVAL: According to the manufacturer, coadministration with a meal high in calories, fat, and protein reduces the absorption of indinavir. In ten patients given indinavir in this manner, the peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) of indinavir decreased by an average of 84% and 77%, respectively. In contrast, grapefruit juice may have only minor effects on the oral bioavailability of indinavir. The manufacturer's package labeling states that administration of a single 400 mg dose of indinavir with 8 oz. of grapefruit juice decreased indinavir AUC by an average of 26%. Likewise, a study consisting of 14 HIV-infected subjects found no uniform nor significant changes in steady-state indinavir AUC during administration with double-strength grapefruit juice compared to water. There was, however, a delay in absorption (Tmax) due to grapefruit juice that is unlikely to be of clinical significance.
MANAGEMENT: To ensure maximal oral absorption, indinavir should be administered without food but with water 1 hour before or 2 hours after a meal. Alternatively, indinavir may be administered with other liquids such as skim milk, juice, coffee, or tea, or with a light meal (e.g., dry toast with jelly, juice, and coffee with skim milk and sugar; corn flakes, skim milk and sugar).
References (3)
- (2001) "Product Information. Crixivan (indinavir)." Merck & Co., Inc
- Yeh KC, Deutsch PJ, Haddix H, Hesney M, Hoagland V, Ju WD, Justice SJ, Osborne B, Sterrett AT, Stone JA, Woolf E, Waldman S (1998) "Single-dose pharmacokinetics of indinavir and the effect of food." Antimicrob Agents Chemother, 42, p. 332-8
- Shelton MJ, Wynn HE, Newitt RG, DiFrancesco R (2001) "Effects of grapefruit juice on pharmacokinetic exposure to indinavir in HIV-positive subjects." J Clin Pharmacol, 41, p. 435-42
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.